Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
Back to Faculty/Researchers
Prof. J Christopher Love
Raymond A (1921) and Helen E St. Laurent Professor of Chemical Engineering
Associate Member, Broad Institute
Graduate Admissions Officer (Chem-E)
Primary DLC
Department of Chemical Engineering
MIT Room:
76-253
(617) 324-2300
clove@mit.edu
https://cheme.mit.edu/profile/j-christopher-love/
Assistant
Mariann Murray
(617) 253-0632
mariann@mit.edu
Areas of Interest and Expertise
Micro/Nanofabrication and Surface Chemistries
Cellular Immunology and Infectious Diseases
Immunotherapy/Vaccines
Clinical Diagnostics
T-Cell Activation
Single Cell Analysis
Cellular Arrays
Nanowells
Circulating Tumor Cells
Research Summary
The Love Lab is exploring the heterogeneity present in populations of cells and characterizing the dynamic biological responses of individual cells subjected to defined perturbations. We develop new processes for analyzing large numbers of individual living cells quantitatively and dynamically. The primary approach uses simple technologies, based on soft lithography or unconventional nanofabrication, to measure multiple characteristics of single cells, and from those data, we aim to construct detailed profiles that describe the state and evolution of the cell itself or the multicellular population of which it is a member.
The long-term objectives of the Lab's work is to understand how heterogeneity in populations of cells affects their collective behaviors as a system, and to gain insights into the biological variations present in unique and rare cells from those populations. Another aim is to facilitate the transfer of these technologies into clinical laboratories for extended use in biomedical research.
Recent Work
Projects
August 1, 2018
Koch Institute for Integrative Cancer Research (KIICR)
The AltHost Consortium
Principal Investigator
J Love
October 22, 2008
Department of Chemical Engineering
Love Lab
Principal Investigator
J Love
October 22, 2008
Department of Chemical Engineering
High-Throughput and High-Content Screening for Monoclonal Antibodies
Principal Investigator
J Love
October 22, 2008
Department of Chemical Engineering
Microtools for Profiling Immune Responses
Principal Investigator
J Love
October 22, 2008
Department of Chemical Engineering
Microfluidic Systems for Live Cell Imaging
Principal Investigator
J Love
Video
11.15-16.23-RD-Love
November 16, 2023
Conference Video
Duration: 29:51
Show more
The Promise of Biomanufacturing
4.4.23-Health-Love
April 4, 2023
Conference Video
Duration: 34:48
Show more
Accelerating Manufacturing and Translation of Biologic Medicines Using Alternative Hosts
3.23.21-Health-J-Christopher-Love
March 23, 2021
Conference Video
Duration: 16:51
Show more
J Christopher Love
Professor, Chemical Engineering
Associate Member, Broad Institute
Associate Member, Ragon Institute of MGH, MIT and Harvard
J. Christopher Love - 2019 Life Science Conference
December 10, 2019
Conference Video
Duration: 31:36
Show more
Fast and Modular Manufacturing Systems for Biopharmaceuticals and Vaccines
Recombinant biopharmaceuticals and vaccines represent a significant class of therapeutics and preventions. While the industry has established efficient platformed processes for the production of monoclonal antibodies at multi-ton scales, the improved precision of therapeutic indications and expanding molecular designs (such as bispecific antibodies, nanobodies, and others) add new challenges for the timely and cost-effective production of emerging therapeutic concepts. This talk will present an integrated approach to biomanufacturing that combines automated end-to-end production and purification along with a fast and engineering-friendly alternative host to enable a flexible platform for next-generation manufacturing. Examples in both biopharmaceuticals and vaccines will be presented.
2019 MIT Increased Productivity in the Biopharmaceutical Industry Conference
Related Faculty
Ms. Jennifer H Nash
Lecturer
Kai-Jher Tan
Graduate Student
Mr. Joel Michael Dashnaw
Administrative Assistant II